Cumulative mortalities according to significant factors
| . | Cancer-specific mortality (%) . | Competing mortality (%) . | ||||
|---|---|---|---|---|---|---|
| 5 y . | 10 y . | P value . | 5 y . | 10 y . | P value . | |
| All | 2.8 | 4.3 | 7.7 | 21.0 | ||
| Age group, y | .027 | <.001 | ||||
| <60 | 0.8 | 1.4 | 2.3 | 10.6 | ||
| 60-70 | 3.6 | 6.1 | 11.4 | 19.7 | ||
| ≥70 | 5.6 | 7.4 | 13.3 | 39.7 | ||
| Stage | <.001 | .169 | ||||
| I | 1.5 | 1.9 | 7.7 | 19.7 | ||
| II-IV | 5.2 | 8.3 | 7.8 | 22.7 | ||
| Site of origin | .597 | .162 | ||||
| Gastric | 2.9 | 2.9 | 2.6 | 17.5 | ||
| Skin | 1.1 | 2.5 | 2.4 | 15.6 | ||
| Lung | 2.5 | 5.9 | 9.1 | 27.2 | ||
| Orbit | 4.5 | 6.2 | 16.5 | 26.5 | ||
| MALT-IPI risk | <.001 | <.001 | ||||
| Low | 1.1 | 1.6 | 5.3 | 13.0 | ||
| Intermediate | 2.8 | 3.9 | 9.3 | 27.1 | ||
| High | 10.7 | 18.4 | 12.6 | 32.8 | ||
| . | Cancer-specific mortality (%) . | Competing mortality (%) . | ||||
|---|---|---|---|---|---|---|
| 5 y . | 10 y . | P value . | 5 y . | 10 y . | P value . | |
| All | 2.8 | 4.3 | 7.7 | 21.0 | ||
| Age group, y | .027 | <.001 | ||||
| <60 | 0.8 | 1.4 | 2.3 | 10.6 | ||
| 60-70 | 3.6 | 6.1 | 11.4 | 19.7 | ||
| ≥70 | 5.6 | 7.4 | 13.3 | 39.7 | ||
| Stage | <.001 | .169 | ||||
| I | 1.5 | 1.9 | 7.7 | 19.7 | ||
| II-IV | 5.2 | 8.3 | 7.8 | 22.7 | ||
| Site of origin | .597 | .162 | ||||
| Gastric | 2.9 | 2.9 | 2.6 | 17.5 | ||
| Skin | 1.1 | 2.5 | 2.4 | 15.6 | ||
| Lung | 2.5 | 5.9 | 9.1 | 27.2 | ||
| Orbit | 4.5 | 6.2 | 16.5 | 26.5 | ||
| MALT-IPI risk | <.001 | <.001 | ||||
| Low | 1.1 | 1.6 | 5.3 | 13.0 | ||
| Intermediate | 2.8 | 3.9 | 9.3 | 27.1 | ||
| High | 10.7 | 18.4 | 12.6 | 32.8 | ||